Venetoclax with Decitabine or Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia

Res Sq [Preprint]. 2023 Jun 12:rs.3.rs-3015916. doi: 10.21203/rs.3.rs-3015916/v1.
No abstract available

Keywords: AML; hypomethylating agent; refractory; relapsed; venetoclax.

Publication types

  • Preprint